Active Ingredient: Midazolam
As an intramuscular premedication for patients with physical status ASA I-IV who are to undergo surgical procedures.
For this indication, competent medicine agencies globally authorize below treatments:
Intramuscular
0.07 - 0.1 mg per kg of body weight
From 0.07 To 0.1 mg per kg of body weight once every day
A single intramuscular injection of 0.07-0.1mg/kg body-weight, administered 30-60 minutes pre-operatively, has been shown to be adequate in most cases. The usual dose is about 5mg.
Atropine or hyoscine hydrobromide may be given concomitantly, bearing in mind that hyoscine hydrobromide will enhance and prolong the sedative and amnesic effects of midazolam.
Midazolam injection can be combined with atropine or hyoscine hydrobromide in the same syringe to be given as a single intramuscular injection.
Liability Disclaimer : RxReasoner has utilized reasonable care in providing content and services that are accurate, complete and up to date. However, RxReasoner does not accept any responsibility or liability about it. The content and services of RxReasoner are for informational purposes only and they are not intended to be a substitute for the knowledge, expertise, skill, and judgment of physicians, pharmacists, nurses, or other healthcare professionals involved in patient care. RxReasoner offers no medical advice. Users are responsible for the use of the provided content. A shown indication or treatment should not be construed to indicate that the medication is safe, appropriate, or effective in any given patient or under any particular circumstances. The absence of an indication or treatment should not roule out the existence of other appropriate medications. Always seek the advice of a physician or other qualified health provider with any questions you may have regarding a medical condition or medicament. RxReasoner is not liable for any damages allegedly sustained arising out of the use of its content and services.
